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A serine esterase called granzyme A, which is specifically expressed in cytolytic lymphocytes has been char- 
acterized. It is a disulfide-linked dimer and exhibits a trypsin-like specificity cleaving best after Arg. N-termi- 
nal sequence analysis revealed that granzyme A is identical to a protease recently predicted from a cloned 
CTL-specific gene. 
CTL-specljic protein Serine esterase Cytotoxicity 
1. INTRODUCTION 2. MATERIALS AND METHODS 
In an attempt to understand the mechanism of 
target cell lysis mediated by cytolytic lymphocytes, 
three genes specific for CTLs have been recently 
isolated, using subtractive hybridization methods 
[l-3]. Sequence analysis predicts that all three pro- 
teins code for serine proteases and reveal the 
highest degree of homology with rat mast cell pro- 
tease type II. In an alternative approach, proteins 
of the cytolytic granules of cytotoxic lymphocytes 
have been isolated [4,5]. At present the cytolytic, 
pore-forming protein perforin [6,7], which exhibits 
structural and functional homology with comple- 
ment component C9 [8,9], and two serine esterases 
[ 10,l l] have been characterized. However, the link 
between the isolated esterases and the genes is 
missing. Here, we report that one of these 
esterases, denoted granzyme A, contains an 
amino-terminal sequence identical to the one en- 
coded by the CTL-specific gene (H-factor) isolated 
by Gershenfeld and Weissmann [l]. 
* To whom correspondence should be addressed 
2.1. Enzyme assays 
The amidase activity of granzyme A was tested 
on various peptide-7-amino-4-methyl-coumarin 
(AMC) substrates (Bachem, Bubendorf, 
Switzerland). Stocks (10 mM) of the substrates 
were prepared in DMSO and then diluted to 
0.5 mM in a buffer containing 20 mM Tris-HCl, 
pH 7.8, 200 mM NaCl, 3 mM CaC12 and 1 mM 
MgC12. Granzyme A (500 ng) in 20~1 of a buffer 
containing 10 mM Bis-Tris, pH 6.0, 550 mM NaCl 
was added to 80 ~1 of the substrate solution and in- 
cubated at 37°C for 60 min. The reaction was 
stopped by adding 1 ml of 1 M ammonium acetate 
buffer, pH 4.5. Fluorescence intensity was 
measured in a spectrofluorometer SFM23 (Kon- 
tron, Zurich) at an excitation and emission 
wavelength of 380 and 460 nm, respectively. 
Esterase activity of granzyme A was measured us- 
ing thiobenzyl-ester substrates [12] (Bachem). 
360~1 of the substrate reaction mixture (0.2 M 
Tris-HCl, pH 8.1, 2 x 10m4 M thiobenzyl-ester 
substrate and 2.2 x 10m4 M dithiobis (nitrobenzoic 
acid)) was mixed with 40~1 granzyme A (25 ng). 
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After 20 min at room temperature, absorbance 
was read at 405 using an automatic absorption 
reader (Gilford, Model PR-50). The protease ac- 
tivity on azocasein was tested according to 
Coombs [ 131. In brief, granzyme A or trypsin as a 
reference (2 pg each) was added to 500 pg azoca- 
sein in a buffer containing’ 50 mM Tris, pH 8.2, 
and 150 mM NaCl (total volume, 500~1). After 
30 min incubation at 37°C undigested substrate 
and protease were precipitated by the addition of 
500~1 of 10% trifluoroacetic acid. After cen- 
trifugation for 1 min at 10000 x g, the absorbance 
of the acid-soluble azocasein peptides was read at 
366 nm. Relative activity for granzyme A as com- 
pared to trypsin was determined from a standard 
curve using different quantities of trypsin. 
2.2. Purification of granzyme A 
Lytic granules were isolated from the CTL-line 
B6.1. Approx. lo9 cells were lysed by nitrogen 
cavitation and granules isolated on a Percoll densi- 
ty gradient (for exact procedure see [15]). After 
removal of Percoll by high speed centrifugation 
(3 h, 50000 rpm, 4”C, Beckman 60 Ti rotor) in the 
presence of 2 M NaCl, soluble granule proteins 
were passed over a TSK-4000 (2.5 cm x 60 cm) 
column (LKB). All fractions devoid of perforin 
were pooled, concentrated 10 times by ultrafiltra- 
tion (Amicon) and dialyzed against buffer A 
(10 mM Bis-Tris, pH 6.0, 50 mM NaCl). The pro- 
teins were then applied to a FPLC Mono S anion- 
exchange column (HR 5/5, Pharmacia) 
equilibrated in buffer A [lo]. Proteins were eluted 
at a rate of 1 ml/min with a linear salt gradient 
(buffer B: 10 mM Bis-Tris, pH 6.0, 1 M NaCl). 
The fractions containing granzyme A were pooled, 
concentrated by ultracentrifugation and were ap- 
plied to a TSK-2000 gel chromatography column 
equilibrated in 15OmM CHXOONH4, pH 4.5. 
Proteins were eluted at a rate of 1 ml/min. 1 ml 
fractions were collected. Proteins were analysed in 
10% polyacrylamide gels according to Laemmli 
[14]. The proteins were silver stained. 10 mM 
dithiothreitol was included in the sample buffer 
when the protein was analysed under reducing con- 
ditions. 
2.3. Protein sequencing 
Granzyme A isolated by gel chromatography us- 
ing a TSK-2000 column (see fig.1) was lyophilized 
and 400 pmol of the non-reduced protein was sub- 
jected to sequencing. An Applied Biosystems 470 
A protein sequencer was used, and the released 
phenylthiohydantoin-amino acids (PTH-AA) 
analysed by an online Applied Biosystems 120 A 
PTH-AA analyser. 
3. RESULTS AND DISCUSSION 
Granzyme A was isolated from cytoplasmic 
granules of the CTL-line B6.1 [ll], which ex- 
presses cytolytic activity against H-2d targets. 
Granules were isolated by means of Percoll density 
centrifugation. The soluble granule proteins were 
depleted of the pore-forming protein per- 
forin/cytolysin using a TSK-4000 gel filtration col- 
umn [6] and the remainder of the proteins passed 
through a FPLC Mono S cation-exchange column 
[lo]. Two of the eluting proteins could be iden- 
tified as serine esterases [lo] on the basis of their 
reactivity with the radioactive affinity label 
[3H]diisopropylfluorophosphate (DFP). One, 
designated granzyme A, has a molecular mass of 
35 kDa under reducing conditions and cleaves very 
efficiently the substrate u-benzoyl-lysine- 
thiobenzylester (BLT), suggesting a trypsin-like 
substrate specificity. 
Granzyme A is probably identical with the DFP- 
labeled esterase, the activity of which was detected 
in cytolytic lymphocytes by Pasternak and co- 
workers [ 11,161. Their study indicates that this en- 
zyme activity is specifically expressed in cytolytic 
lymphocytes, whereas our investigation showed 
that granzyme A is synthesized during the ap- 
pearance of cytolytic granules in a CTL-hybrid line 
[lo], suggesting a possible role for the protease in 
cytolysis. 
In order to characterize granzyme A better, we 
purified it to homogeneity. Granzyme A- 
containing fractions of the FPLC Mono S column 
were pooled and passed through a TSK-2000 gel 
filtration column. Fig.1 shows the SDS-PAGE 
analysis of the column fractions. Granzyme A 
separated well from the two impurities of lower 
molecular mass. Granzyme A is disulfide linked 
with an apparent molecular mass of 60 kDa. 
Under reducing conditions, only one band of 
35 kDa is detected, suggesting that granzyme A is 
a homo-dimer. 
Earlier studies have indicated that granzyme A 
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Fig. 1. SDS-polyacrylamide electrophoresis of granzyme 
A under non-reducing (a) and reducing conditions (b). 
(a) Analysis of fractions eluting from the TSK-2000 
column, which represents the last purification step of 
granzyme A. As shown in a previous report, the 60 kDa 
protein exhibits trypsin-like esterase activity and reacts 
with the serine esterase affinity label [3H]diisopropyl- 
fluorophosphate. Granzyme A elutes in fractions 17-19 
well separated from two other CTL-granule proteins. (b) 
Fraction 18 was used for sequence analysis and for 
further SDS-polyacrylamide analysis under reducing 
conditions. The following M, standards were used to 
calibrate the gel: bovine serum albumin (67 kDa), 
ovalbumin (43 kDa) and carbonic anhydrase (29 kDa). 
has a trypsin-like specificity [lo]. It cleaves BLT 
(substrate for trypsin) much more efficiently than 
the analogous substrate for chymotrypsin (SPT) 
(table 1). Therefore, several known synthetic 
substrates for trypsin containing the fluorogenic 
group 7-amino-4-methyl-coumarin (AMC) were 
tested. As can be seen in table 1, granzyme A is 
highly active on the substrates Pro-Phe-Arg-AMC, 
Val-Pro-Arg-AMC and to a lesser extent on 
substrates in which Lys instead of Arg is coupled 
to the fluorogenic group (PI position), such as Ala- 
Phe-Lys-AMC. Little or no cleavage was observed 
with other substrates not containing Lys or Arg at 
the PI position. Casein, a protein often used as a 
substrate for demonstrating proteolytic activity 
was also cleaved by granzyme A, although at least 
20 times less efficient than by trypsin. 
predicted proteases encoded by the reported CTL- 
specific genes [ 1,3]. Microsequencing of the intact 
granzyme A showed that the first 25 amino acids 
are identical with the N-terminal of one of the 
predicted CTL-specific proteases [ 11, designated 
H-factor (fig.2). The sequence is clearly distinct 
from the second predicted protease [2], denoted 
CCPI by Lobe and colleagues [2], in spite of the 
fact that H-factor and CCPI have 15 out of 25 
amino acid residues of the presumptive N-terminal 
in common. It is also very unlikely that the N- 
terminal sequence of granzyme A corresponds to 
the one of CCPII, the third predicted CTL-specific 
protease [2], whose N-terminal sequence has not 
yet been determined: CCPII is highly homologous 
to CCPI on the segment containing the reactive 
center and quite distinct from H-factor [l-3]. 
Moreover, in contrast to H-factor, CCPI and 
CCPII have no predicted trypsin-like specificity. 
Granzyme A seems to be present only in Granzyme A possesses several interesting 
cytolytic lymphocytes [ 161, suggesting that this features. Although we have no definite proof, it is 
protein could be identical with one of the three almost certainly a disulfide-linked homo-dimer, 
Table 1 
Relative amidase (esterase) activity of granzyme A 
Substrate Relative Relative 
fluorescence activity 
units (070) 
H-Pro-Phe-Arg-AMC 177.0 100 
BOC-Val-Pro-Arg-AMC 59.4 34 
BOC-Leu-Gly-Arg-AMC 8.8 5 
Sue-Ala-Phe-Lys-AMC 18.1 10 
BOC-Val-Leu-Lys-AMC 8.3 5 
Sue-Gly-Pro-Leu-Gly-Pro-AMC 0.8 0 
Sue-Ala-Ala-Ala-AMC 0.4 0 
Sue-Ala-Ala-Pro-Val-AMC 4.1 2 
SBz-Cys-Bzl-AMC 0.6 0 
Absorb- 
ance405 
N-a-benzyloxoycarbonyl-Lys- 
thiobenzyl ester (BLT) 
Sue-Ala-Ala-Pro-Phe-thiobenzyl 
0.86 100 
ester (SPT) 0.07 8 
Absorb- 
ance366 
Azocasein Granzyme A 0.26 4 
Trypsin 0.907 100 
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Fig.2. N-terminal sequence analysis of granzyme A. The amino acid residues of granzyme A are compared to the 
primary structure of H-factor, cytotoxic-T-cell specific protein I (CCPI). For the third predicted CTL-specific protease 
(CCPII), no N-terminal sequence has been determined. Due to the highest homology of CCPI and H-factor to rat mast 
cell protease II (RMCP II), this sequence is included for comparison. The regions containing identical residues are 
boxed. 
since N-terminal amino acid sequence and elec- 
trophoretic analysis reveal only one distinct 
polypeptide chain. Most likely, cysteine-76 of 
granzyme A is involved in the interchain disulfide 
bridge. The molecule predicted by the gene con- 
tains nine cysteines, and by analogy to other 
members of the serine protease superfamily [17], 
such as elastase, Cys-26 and Cys-44, Cys-120 and 
Cys-189, Cys-150 and Cys-168, and Cys-179 and 
Cys-204 of granzyme A form intrachain disulfide 
bonds. 
By analogy to the substrate binding site of tryp- 
sin, Asp-177 confers upon granzyme A a trypsin- 
like specificity, cleaving best after Arg and Lys. Of 
the AMC substrates tested, Pro-Phe-Arg-AMC 
was the most sensitive one. It contains a prolyl 
residue at the P3 position. Peptides of this type are 
not cleaved by most other serine proteases in a way 
which releases the chromogenic group [18]. There 
are however, some exceptions: e.g. rat mast cell 
proteases (RMCP) catalyze the release of p- 
nitroanilide from N-Suc-Ala-Pro-Leu-Phe-p- 
nitroanilide, and it is interesting to note that gran- 
zyme A shows the highest sequence homology with 
RMCP II [l-3]. 
Gershenfeld and Weissmann [l] deduced from 
the CTL-specific gene a protein sequence contain- 
ing 246 amino acid residues. By analogy to RMCP 
II, they concluded that the active enzyme starts at 
position 15 (Ile), which we confirmed with the N- 
terminal sequence analysis of granzyme A. Since 
the preceding amino acid residues do not have the 
characteristics of a leader peptide, they most likely 
represent the pre-sequence of granzyme A. In- 
terestingly, the amino acid before the N-terminus 
of the active enzyme is an arginine, suggesting the 
possibility that granzyme A activates itself. This 
may occur during exocytosis of the granules, where 
the acidic pH of the granules is changed to neutral 
pH. Granzyme A is active at pH 7.0, but not at pH 
5.0 and is therefore probably inactive in granules. 
In addition, due to its basic nature, granzyme A 
binds very well to proteoglycans, such as heparin 
and chondroitin-sulfate A (not shown). The latter 
molecule is a constituent of granules of cytolytic 
lymphocytes [19] and may further contribute to 
maintain granzyme A in an inactive form within 
the granules. 
As to the actual physiological role of this pro- 
tease, nothing is known at present. In our previous 
report we demonstrated that granule-mediated 
cytolysis is not affected by inhibitors of granzyme 
A [lo]. This observation is in contrast to several 
reports indicating that high and low molecular 
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mass protease inhibitors block NK- and CTL- 
mediated target cell lysis [20-221. Two other CTL- 
specific genes coding for proteases [2,3], and a se- 
cond esterase (granzyme B) in CTL-granules [lo] 
have been characterized. This may mean that a 
protease cascade similar to the complement and 
clotting systems may be involved in lymphocyte 
cytotoxicity. Future studies using the purified en- 
zymes may allow one to examine this notion. 
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